ÂÜÀòÂÒÂ×

Eben Tessari has over fifteen years of experience in the pharmaceutical and biotech industries. Eben is currently the Chief Business Officer at Kiniksa Pharmaceuticals. Prior to joining Kiniksa, Eben served as the Senior Director of Business Development at Synageva BioPharma Corp., Director of Corporate & Business Development at Civitas Therapeutics, and Associate Director of Business Development at Zalicus Incorporated.

Eben began their career in the industry as a Research Associate at Millennium Pharmaceuticals in 2005. Eben then joined EPIX Pharmaceuticals as a Business Development Associate in 2007. In 2010, they joined Vertex Pharmaceuticals as a Senior Manager for New Product Strategy & Decision Analytics.

Eben has a proven track record of successfully leading and executing business development initiatives that have resulted in significant growth for their companies. Eben is a strategic thinker with a deep understanding of the drug development process and a passion for bringing new treatments to patients.

Eben Tessari has a JD from Suffolk University Law School in Intellectual Property Law, an MBA from Suffolk University - Sawyer Business School in Banking, Corporate, Finance, and Securities Law, an MS in Biomedical Engineering from Boston University, and a BS in Neuroscience from Northeastern University.

Their manager is Sanj K. Patel, CEO & Chairman. Eben Tessari works with Martina Struck - SVP, Regulatory Affairs, John Paolini - CMO, and Carsten Boess - EVP Corporate Affairs.